Drug Controller General of India

US FDA Denies Bharat Biotech’s Covaxin Emergency Use Approval

Dr Reddy’s Revealed More About 2-DG, and Its Approval Is More Confusing Now

DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines

COVID-19: Antibody Cocktail Treatment Begins at Delhi’s Sir Ganga Ram Hospital

Will Make, Supply 10 Cr Covishield Doses in June: Serum Institute to Centre

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us

‘B.1.617.2 May Be 50% More Contagious Than Variant First Seen in UK’